Mind Medicine MindMed (MNMD)
(Real Time Quote from BATS)
$7.50 USD
+0.03 (0.40%)
Updated Jul 12, 2024 10:30 AM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MNMD 7.50 +0.03(0.40%)
Will MNMD be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MNMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MNMD
Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year?
Are Medical Stocks Lagging Mind Medicine MindMed (MNMD) This Year?
MNMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why
MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag
What Makes Mind Medicine (MindMed) Inc. (MNMD) a New Buy Stock
Other News for MNMD
MindMed to be Included in Russell 2000® and Russell 3000® Indexes
Mind Medicine files automatic mixed securities shelf
Mind Medicine to join Russell 2000 index
Mind Medicine to be included in Russell 2000, 3000 Indexes
Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M